We’re proud to announce that Icarus Therapeutics has been selected to present at the AI Insiders: AI in Healthcare & Biotech Startup Showcase during the J.P. Morgan Healthcare Conference 2026 in San Francisco.
The event will take place at the Verizon Innovation Lab, bringing together a highly curated group of startups, investors, and industry leaders at the intersection of artificial intelligence and life sciences.
A Global Stage for Innovation
The J.P. Morgan Healthcare Conference is one of the most influential gatherings in the healthcare and biotech ecosystem. Being selected to present alongside other forward-thinking companies is both an honor and a validation of the work we’re building at Icarus.
The AI Insiders showcase specifically highlights companies leveraging AI to transform healthcare and biotechnology—a space where precision, speed, and innovation are redefining what’s possible.
Why This Matters
At Icarus Therapeutics, we are focused on advancing next-generation therapeutic solutions, and AI is increasingly central to how the industry accelerates discovery, development, and decision-making.
Presenting at this showcase gives us the opportunity to:
-
Share our vision with a global audience of investors and partners
-
Engage with leaders shaping the future of AI-driven biotech
-
Position Icarus within a rapidly evolving innovation landscape
-
Build relationships that can accelerate our path forward
Momentum Into 2026
This opportunity reflects the growing momentum behind Icarus Therapeutics as we continue to expand our presence across key industry platforms—from regional innovation ecosystems to global stages like JPM.
From Philadelphia to San Francisco, we’re actively engaging with the communities, partners, and capital networks that will help shape our next phase of growth.
Looking Ahead
We’re excited to take the stage, share what we’re building, and connect with others who are equally committed to transforming healthcare through innovation.
If you’ll be in San Francisco during JPM 2026, we’d love to connect.
The future of biotech is being built at the intersection of science and AI—and we’re just getting started.